491
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Expression and significance of silent information regulator two homolog 1 in the placenta and plasma of patients with pre-eclampsia—a meta-analysis

, , , &
Article: 2264983 | Received 05 Jul 2023, Accepted 25 Sep 2023, Published online: 19 Oct 2023

References

  • Tochio A, Obata S, Saigusa Y, et al. Does pre‐eclampsia without proteinuria lead to different pregnancy outcomes than pre‐eclampsia with proteinuria? J Obstet Gynaecol Res. 2019;45(8):1–9. doi: 10.1111/jog.14017.
  • Guida JP, Parpinelli MA, Surita FG, et al. The impact of proteinuria on maternal and perinatal outcomes among women with pre‐eclampsia. Int J Gynaecol Obstet. 2018;143(1):101–107. doi: 10.1002/ijgo.12487.
  • Dimitriadis E, Rolnik DL, Zhou W, et al. Pre-eclampsia. Nat Rev Dis Primers. 2023;9(1):8. doi: 10.1038/s41572-023-00417-6.
  • Hod M, Kapur A, Sacks DA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynecol Obstet. 2015;131:S173–S211. doi: 10.1016/S0020-7292(15)30007-2.
  • Magee LA, Brown MA, Hall DR, et al. The 2021 international society for the study of hypertension in pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27:148–169. doi: 10.1016/j.preghy.2021.09.008.
  • Tossetta G, Fantone S, Piani F, et al. Modulation of NRF2/KEAP1 signaling in preeclampsia. Cells. 2023;12(11):1545. doi: 10.3390/cells12111545.
  • Fantone S, Mazzucchelli R, Giannubilo SR, et al. At-rich interactive domain 1A protein expression in normal and pathological pregnancies complicated by preeclampsia. Histochem Cell Biol. 2020;154(3):339–346. doi: 10.1007/s00418-020-01892-8.
  • Tossetta G, Fantone S, Balercia G, et al. Preeclampsia and severe acute respiratory syndrome coronavirus 2 infection: a systematic review. J Hypertens. 2022;40(9):1629–1638. doi: 10.1097/HJH.0000000000003213.
  • Griffin M, Heazell AE, Chappell LC, et al. The ability of late pregnancy maternal tests to predict adverse pregnancy outcomes associated with placental dysfunction (specifically fetal growth restriction and pre-eclampsia): a protocol for a systematic review and meta-analysis of prognostic accuracy studies. Syst Rev. 2020;9(1):78. doi: 10.1186/s13643-020-01334-5.
  • Liu M, Yin Y, Yu H, et al. Laminins regulate placentation and pre-eclampsia: focus on trophoblasts and endothelial cells. Front Cell Dev Biol. 2020;8:754. doi: 10.3389/fcell.2020.00754.
  • Vaiciulis P, Liutkeviciene R, Liutkevicius V, et al. Association of SIRT1 single gene nucleotide polymorphisms and serum SIRT1 levels with laryngeal squamous cell carcinoma patient survival rate. Cancer Biomark. 2022;34(2):175–188. doi: 10.3233/CBM-210264.
  • Lappas M, Mitton A, Lim R, et al. SIRT1 is a novel regulator of key pathways of human labor. Biol Reprod. 2011;84(1):167–178. doi: 10.1095/biolreprod.110.086983.
  • Zhao X, Wu Y, Li J, et al. JNK activation-mediated nuclear SIRT1 protein suppression contributes to silica nanoparticle-induced pulmonary damage via p53 acetylation and cytoplasmic localisation. Toxicology. 2019;423:42–53. doi: 10.1016/j.tox.2019.05.003.
  • Pei J, Liu Z, Wang C, et al. Progesterone attenuates sirt1-deficiency-mediated pre-eclampsia. Biomolecules. 2022;12(3):422. doi: 10.3390/biom12030422.
  • Ge TJ, Kong JY. Clinical value of serum SIRT1 combined with uterine hemodynamics in predicting disease severity and fetal growth restriction in preeclampsia. Evidence-Based Complementary and Alternative Med. 2023;2023:1–12. doi: 10.1155/2023/1744625.
  • Yang Z, Zhang W. Guidelines for the diagnosis and treatment of hypertensive disorders in pregnancy. Chin J Obst Gynecol. 2020;55:227–238.
  • Magee LA, Pels A, Helewa M, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertens. 2014;4(2):105–145. doi: 10.1016/j.preghy.2014.01.003.
  • Sinkey RG, Battarbee AN, Bello NA, et al. Prevention, diagnosis, and management of hypertensive disorders of pregnancy: a comparison of international guidelines. Curr Hypertens Rep. 2020;22(9):66. doi: 10.1007/s11906-020-01082-w.
  • Liu J-Y, Chen C, Yang X-Y, et al. Silence information regulator 2 homolog 1 participates in the pathogenesis of preeclampsia by regulating vascular endothelial growth factor A. Chinese J Family Plan Gynecotokol. 2023;14(3):31–35.
  • Yang Q, Yuan Y-C, Tang X-H. Expression of SIRT1 and SIRT3 in placental tissues of pre-eclampsia women and its correlation with maternal prognosis. Modern Med J. 2020;48(9):1124–1129.
  • Zhou B-H, Qiu J, Tian Y-J, et al. Expressions and significance of MiR-34a and SIRT1 in placenta of patients with preeclampsia. Hebei Med J. 2020;42(8):1144–1147.
  • Jiang T, Xue X-Z. Expressions and clinical significances of silent information regulator 1 and nod like receptor protein 3 in placenta tissues of pregnant women with preeclampsia. Chinese J Family Plan. 2023;31(3):658–661.
  • Li H, Wang P, Huang C-X, et al. Inhibition of SIRT1 expression by miR-34a regulates proliferation and apoptosis of human trophoblast cell. Acta Universitatis Medicinalis Anhui. 2020;55(12):1915–1920.
  • Cao D, Tang X-F, Li M-H. miR-155-5p influences the occurrence of preeclampsia through targeted inhibition of Sirt1. J Practical Med. 2021;37(4):451–457.
  • Broady AJ, Loichinger MH, Ahn HJ, et al. Protective proteins and telomere length in placentas from patients with pre-eclampsia in the last trimester of gestation. Placenta. 2017;50:44–52. doi: 10.1016/j.placenta.2016.12.018.
  • Viana-Mattioli S, Nunes P, Cavalli R, et al. Analysis of SIRT1 expression in plasma and in an in vitro model of preeclampsia. Oxid Med Cell Longev. 2020;2020:4561083–4561087. doi: 10.1155/2020/4561083.
  • Poidatz D, Dos Santos E, Duval F, et al. Involvement of estrogen-related receptor-γ and mitochondrial content in intrauterine growth restriction and preeclampsia. Fertil Steril. 2015;104(2):483–490. doi: 10.1016/j.fertnstert.2015.05.005.
  • Zhang H, Wei X, Li M. The expression of Sirt1/FoxO1 pathway in the placenta of patients with preeclampsia and its connection with prognosis. J Obstet Gynaecol. 2022;42(8):3514–3521. doi: 10.1080/01443615.2022.2151347.
  • Ma L-Y, Chen W-W, Gao R-L, et al. China cardiovascular diseases report 2018: an updated summary. J Geriatr Cardiol: JGC. 2020;17(1):1.
  • Fodor P, White B, Khan R. Inflammation—the role of ATP in pre‐eclampsia. Microcirculation. 2020;27(1):e12585. doi: 10.1111/micc.12585.
  • de Knegt VE, Hedley PL, Kanters JK, et al. The role of leptin in fetal growth during pre-eclampsia. Int J Mol Sci. 2021;22(9):4569. doi: 10.3390/ijms22094569.
  • Mahmoud SA, Abdel-Aziz MM, Khafaga RH, et al. The pre-conception maternal exposure to sofosbuvir affects the mitochondrial biogenesis in prenatal fetal tissues: experimental study on rats. Mol Med. 2023;29(1):1–14. doi: 10.1186/s10020-023-00666-x.
  • Bramora P, Borymska W, Zych M, et al. Effect of naringenin on oxidative stress in the heart tissue of type 1 diabetic wistar rats. Acta Poloniae Pharmaceutica. 2022;79(5).
  • Wang P, Huang C-X, Gao J-J, et al. Resveratrol induces SIRT1-Dependent autophagy to prevent H2O2-Induced oxidative stress and apoptosis in HTR8/SVneo cells. Placenta. 2020;91:11–18. doi: 10.1016/j.placenta.2020.01.002.
  • Pankiewicz K, Issat T. Understanding the role of chemerin in the pathophysiology of Pre-Eclampsia. Antioxidants. 2023;12(4):830. doi: 10.3390/antiox12040830.
  • Yin L, Xu L, Chen B, et al. SRT1720 plays a role in oxidative stress and the senescence of human trophoblast HTR8/SVneo cells induced by D-galactose through the SIRT1/FOXO3a/ROS signalling pathway. Reprod Toxicol. 2022;111:1–10. doi: 10.1016/j.reprotox.2022.05.001.
  • Munro SK, Balakrishnan B, Lissaman AC, et al. Cytokines and pregnancy: potential regulation by histone deacetylases. Mol Reprod Dev. 2021;88(5):321–337. doi: 10.1002/mrd.23430.
  • Wang Y, Zhang Y, Wu Y, et al. SIRT1 regulates trophoblast senescence in premature placental aging in preeclampsia. Placenta. 2022;122:56–65. doi: 10.1016/j.placenta.2022.04.001.